COO Willem van Oort

About Aimm Therapeutics
COO Willem van Oort

Management

COO Willem van Oort, PhD

Willem van Oort joined AIMM at its founding, bringing over 30 years of experience in business development and shaping and managing start-up companies. Previously, van Oort served as general manager of Licentec, a commercial technology transfer company, where he established more than 150 global R&D-alliances and licensing agreements. Van Oort founded and managed two seed capital funds and several university spin-offs including Pepscan, AMT, Add2X Biosciences, C-Très and Arthrogen. He was also founder of the Amsterdam Medical Center’s (University of Amsterdam) Technology Transfer Office.